Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Olanow

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Parkinsonism & Related Disorders|July 2, 2008
A rational approach to the treatment of early Parkinson's diseaseC W Olanow
Journal of Neural Transmission. Supplementum|January 1, 1996
Deprenyl in the treatment of Parkinson's disease: clinical effects and speculations on mechanism of actionC W Olanow
European Neurology|January 1, 1992
Early therapy for Parkinson's diseaseC W Olanow
Annals of the New York Academy of Sciences|April 24, 2004
Manganese-induced parkinsonism and Parkinson's diseaseC W Olanow
European Journal of Neurology|December 5, 2002
Surgical therapy for Parkinson's diseaseC W Olanow
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1992
A rationale for dopamine agonists as primary therapy for Parkinson's diseaseC W Olanow
Archives of Neurology|February 19, 2000
Tolcapone and hepatotoxic effects. Tasmar Advisory PanelC W Olanow
Neurology|October 1, 1990
Oxidation reactions in Parkinson's diseaseC W Olanow
Trends in Neurosciences|November 1, 1993
A radical hypothesis for neurodegenerationC W Olanow
Journal of Neural Transmission. General Section|January 1, 1993
A scientific rationale for protective therapy in Parkinson's diseaseC W Olanow
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Parkinsonism & Related Disorders|July 2, 2008
A rational approach to the treatment of early Parkinson's diseaseC W Olanow
Journal of Neural Transmission. Supplementum|January 1, 1996
Deprenyl in the treatment of Parkinson's disease: clinical effects and speculations on mechanism of actionC W Olanow
European Neurology|January 1, 1992
Early therapy for Parkinson's diseaseC W Olanow
Annals of the New York Academy of Sciences|April 24, 2004
Manganese-induced parkinsonism and Parkinson's diseaseC W Olanow
European Journal of Neurology|December 5, 2002
Surgical therapy for Parkinson's diseaseC W Olanow
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1992
A rationale for dopamine agonists as primary therapy for Parkinson's diseaseC W Olanow
Archives of Neurology|February 19, 2000
Tolcapone and hepatotoxic effects. Tasmar Advisory PanelC W Olanow
Neurology|October 1, 1990
Oxidation reactions in Parkinson's diseaseC W Olanow
Trends in Neurosciences|November 1, 1993
A radical hypothesis for neurodegenerationC W Olanow
Journal of Neural Transmission. General Section|January 1, 1993
A scientific rationale for protective therapy in Parkinson's diseaseC W Olanow
Pageof 13